Entrepreneurs First

I've been thinking about what separates the people who build something that matters from those who don't. It's rarely a head start. Some of the most driven founders I've met came into the room knowing they weren't first. Most of them were not handed the obvious path, and that's often the thing that made them want to become unstoppable. Not being first doesn't disqualify you. For the right person, it's the whole point. The Bridge exists for people like that. People who feel capable of more than their current environment allows. Who want to find their life's work, surrounded by others who match their level of ambition, single-mindedness, and hunger. If that's you, you know it. The deadline for the Bridge is this Monday. Link in comments to apply. David Ola Daryna Hrybchuk Max R Maxwell Filip-Turner Maxence Jamet Dominik Diak Hanne Mortazavi

After chatting with 100+ people at Entrepreneurs First, I have realised that most ambitious people aren't stuck because they lack ability—they’re stuck because they believe the wrong things. The things which they believe in sound reasonable. That’s the problem. They’re not constraints—they’re beliefs. And many of them are quietly wrong. I have tried to condense those insights into an article. Link below :)

At Entrepreneurs First we’re obsessed with the power of cofounders. Magic doesn’t come from an idea, it comes from the unique combinations of people and what they can create. I’ve watched individuals go from stuck to unstoppable almost overnight. Not because they worked harder, but because they found the right counterpart. I’ve been lucky enough to experience this with Matt Clifford. From taking our earliest cohorts to 10 Downing Street (just to prove EF was legit 😂 ), to opening our first office in San Francisco over a decade later. Matt has fundamentally changed how I think, how I operate, and what I believe is possible. And that’s the thing about great cofounders, they don’t just help you build a company, they change your trajectory. If you want to build something ambitious, WHO you build with might be the most important decision you make. Looking for a cofounder? DM me and see how EF can help.

A big week for Noah Labs 🚀 We are thrilled to share two important milestones! 1. Noah Labs Vox™ has received FDA Breakthrough Device Designation — a recognition by the FDA that Vox™ is on the path to fundamentally change heart failure care. This designation also expedites Noah Labs’ upcoming clearance and commercial activities 🇺🇲 🇪🇺 2. The Investment Bank of Brandenburg (ILB) has awarded us a €3 million ProFIT grant – to further support Noah Labs Vox™. Find the press release in the comments 👇 Thank you to our clinical partners, advisors, and investors who are on this journey with us. 🫀 Stiftung Deutsches Herzzentrum, Deutsches Herzzentrum der Charité (DHZC), Charité - Universitätsmedizin Berlin, Mayo Clinic, University of California, San Francisco, Maastricht UMC+, Hospital Clínic de Barcelona Nina Capital, adesso ventures, Catalpa Ventures, American Heart Association #NoahLabs #MedTech #HeartFailure #DigitalHealth #FDA #Innovation

Today, we’re launching OpenReward. An open platform for serving reinforcement learning environments at scale, designed for training or evaluation. What you get: -330+ RL environments through a single API -4.5M+ unique RL tasks -Autoscaled sandbox compute -Works seamlessly with frameworks like Tinker, Miles, and Slime -Interoperable with any training library We focused on doing one thing well: serving RL environments at scale in a way that’s open and sharable. Launching with 330+ environments, including: -NeMo Gym collection from NVIDIA -SWE-rebench-v2 from Nebius -SETA from Eigent AI -Endless Terminals from Kanishk Gandhi OpenReward is now live in public beta. Let us know your feedback! -General Reasoning product release: https://lnkd.in/e5jhiUEd -OpenReward platform: https://www.openreward.ai/

3 years ago, I left my former company, Nestlé, with a conviction: the Petri dish belongs to the past. Our industry needs something radically different. I met Maxime Mistretta, PhD. and Mohamed Tazi. We built Spore.Bio and started iterating. It took us 3 years. Today, a new technology is born: introducing TMSI™ — Transformer-Based Multimodal Spectral Imaging. Microbiology is complex. Millions of microorganisms. Billions of matrices. Trillions of combinations. We built a deep learning model capable of grasping it all, delivering reliable quantification, detection, and identification in 10 minutes instead of days. And in just 3 years, we’ve generated and published validation data at a speed never seen before in microbiology history. This is the first step toward a new chapter for our industry. In the coming weeks and months, we’ll publish more. Much more. We’re just getting started.